Delivery Order SPE2DB20D2104-SPE2DB23FV54A

Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,567,016,240 units of Methimazole 10 mg tablets. The firm-fixed-price delivery order contract, valued at $1,178.78, has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $31,972.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,690 units of the pharmaceutical product Methimazole 5 mg Tablet in 100 count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,083.56 firm fixed price Delivery Order is for the supply of 4,565,793,350 tablets of Methimazole 10 mg, with a completion date of September 16, 2024. This award does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,572.06 firm fixed price delivery order is for the supply of Methimazole 5 mg tablets. The contract has an ultimate completion date of March 25, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a broader indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methimazole 5 mg tablets. The contract has a ceiling value of $3,480.86 and a completion date of October 6, 2023. The contract type is a Delivery Order under a Firm Fixed Price pricing arrangement. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,551.17, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the supply of 4,566,135,029 units of Methimazole 5 mg tablets, with an ultimate completion date of October 18, 2024. The contract type is Firm Fixed Price, and the pricing is Firm Fixed Price. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,031.00, is a Firm Fixed Price Delivery Order for the supply of Methimazole 5 mg tablets. The contract has an ultimate completion date of November 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,385.67 and an ultimate completion date of December 5, 2022. It covers the procurement of 4,559,255,829 units of the medication Methimazole 5 mg tablets in 90-count packages. This award is not associated with a set-aside program. AmerisourceBergen, a for-profit...
This federal contract award is for the delivery of Methimazole 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $2,185.98, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,567,111,751 Methimazole 10 mg tablets in 100-count bottles. The contract has a ceiling value of $3,943.13 and a completion date of February 3, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FV54A
    Delivery Order

This federal contract award is for the delivery of 4,562,316,121 units of Methimazole 5 mg tablets, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price, valued at $5,878.89, and has an ultimate completion date of September 27, 2023.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award Management (SAM.gov) since 2002. The company maintains significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for providing a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs. This particular award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 1:16 PM